Latest Interviews
Showing 361–375 of 2,089 transcripts.
Clear all filters- Milken Institute1h 14m
Navigating a Changing Global Economy | Middle East and Africa Summit 2024
Laura Deal Lacey, Michael Milken, His Royal Highness Prince Turki Al Faisal Al Saud, Makhtar Diop, Mohamed Mansour, Alan Schwartz, Prince Turki Al Faisal Al Saud
Held in Abu Dhabi in December 2024, the 6th Annual Middle East and Africa Summit convened global leaders from the Milken Institute, the International Finance Corporation, and the Mansour Group to mobilize capital toward healthcare, economic development, and environmental sustainability. The event highlighted a strategic pivot where emerging markets are transforming from passive capital providers into technology hubs capable of bridging the gap between the aging Global North and Africa's young, growing workforce. Participants addressed critical investment barriers such as regulatory uncertainty and currency mismatches by proposing blended finance models and de-risking strategies to unlock trillions of dollars in private and philanthropic resources.
- Milken Institute20 min
A Conversation with CMS Director of Medicare Meena Seshamani | Future of Health Summit 2024
Meena Seshamani, Bertha Coombs
A multidisciplinary team comprising experts from drug pricing, pharmacy, and economics has implemented health care reforms focused on treating developmental issues, chronic illnesses, and behavioral health within the Medicare and Medicaid systems. These initiatives, which include updating risk adjustment methodologies and navigating the Inflation Reduction Act, aim to reduce prescription drug costs for seniors and integrate services to address over 400,000 additional conditions. With a target deadline of September 1st for international financial agreements, the organization plans to execute these changes over five to eight months while utilizing new communication platforms and patient feedback to ensure system stability.
- Milken Institute1h 1m
Decoding Disease: Can Genetics Unlock New Interventions? | Future of Health Summit 2024
Conor Hale, Colleen Campbell, Lon Cardon, Bernard Kwabi-Addo, Benjamin Neale
Experts highlight that while genomic knowledge has expanded to 12,000 identified variants, translating these discoveries into clinical care remains hindered by insurance barriers, provider literacy gaps, and biased data representation. To overcome these bottlenecks, the field is increasingly leveraging artificial intelligence for tumor heterogeneity analysis and shifting toward deconstructing common diseases into rare, monogenic subsets for targeted therapies. With sequencing costs dropping to roughly $200, stakeholders anticipate widespread population screening programs and systematic variant analysis across human diseases becoming feasible within the next decade.
- Milken Institute53 min
Health Care of the Future | Future of Health Summit 2024
Michael Milken, Alex Azar, Buddy Carter, Diana DeGette, Renee Wegrzyn
The event detailed how ARPA-H and legislative initiatives like "Cures 2.0" are addressing systemic healthcare challenges by funding high-risk biomedical innovations and ensuring pharmaceutical independence. Key figures including Rep. Diana DeGette and Rep. Chris Carter highlighted strategies to reform Medicare Advantage payment models and repatriate drug manufacturing to counter supply chain vulnerabilities. The panel concluded with a call for increased federal investment in translational science and a broader call for business leaders to enter government to sustain the pace of medical breakthroughs.
- Milken Institute20 min
A Conversation with FDA Commissioner Robert Califf | Future of Health Summit 2024
Commissioner Califf reflects on his tenure managing the Abbott infant formula recall and reorganizing the FDA Food Program, emphasizing that the agency faces a healthcare delivery crisis rather than an innovation deficit despite the U.S. global leadership in scientific advancement. He advocates for shifting regulatory focus from pre-approval trials to post-market pragmatic studies and new frameworks for AI decision support to address systemic biases and monitor uncontrolled algorithmic drift in clinical environments. Califf concludes by defining essential traits for future leadership, prioritizing executive listening skills and a commitment to high-quality evidence generation while maintaining a strict separation between science-based product decisions and politically influenced policy mandates.
- Milken Institute43 min
Partnerships Leading to a Healthier Tomorrow | Future of Health Summit 2024
Meg Tirrell, Yele Aluko, John Crowley, Kody Kinsley, Pablo Legorreta
Moderated by a panel including BIO President John Crowley and North Carolina HHS Secretary Cody Kinsley, industry leaders and officials discussed strategies to overcome systemic inefficiencies and reduce the $500 billion in annual waste within the US healthcare sector. Speakers highlighted North Carolina's successful Medicaid expansion and debt relief initiatives as a model for addressing social determinants of health, while advocating for regulatory reforms and non-dilutive financing to accelerate biotechnology innovation. The dialogue concluded with a unified call to shift the industry focus from reactive volume-based care to preventive measures and equitable access, emphasizing the role of technology in creating a more sustainable and efficient national health system.
- Milken Institute1h 11m
Global Collaboration to Eradicate Women’s Cancers | Future of Health Summit 2024
Alice Park, Usman Malami Aliyu, Danielle Carnival, Dave Fredrickson, Roberta Lipson, Gemma Peters
Global cancer leaders convened to address the projected doubling of incidence in low- and middle-income countries by implementing diverse strategies ranging from Nigeria's mobile screening vans and mobile PCR labs in China to the UK's data-driven risk assessment partnerships. These initiatives prioritize overcoming structural inequities in treatment access, financial barriers, and clinical trial participation through innovations like AI-driven imaging, drug repurposing, and targeted care navigation programs. Ultimately, the consensus emphasizes that sustainable national cancer control plans must integrate geopolitical cooperation and equity-first designs to prevent the fragmentation of global research and ensure effective prevention for the most vulnerable populations.
- Milken Institute58 min
Innovation for All: Strategies for Maximizing Impact | Future of Health Summit 2024
Matthew Herper, Jay Bradner, Debi Brooks, Lisa D. Earnhardt, Elizabeth Fowler, Marc Samuels
This event synthesized breakthroughs in Parkinson's biomarker detection, the genetic discovery of obesity-protective alleles, and strategies to expand medical device access for underserved populations. Industry leaders and regulators discussed how these scientific advances confront systemic barriers in delivery and reimbursement, particularly regarding the high costs of gene therapies and the misalignment of current billing models with preventative care. The consensus emphasized that future progress depends on shifting focus from pure biological innovation to collaborative frameworks that ensure scalable manufacturing, equitable access, and payment reforms based on patient outcomes.
- Milken Institute1h 0m
Why Younger People Are Getting Cancer and What We Can Do About It | Future of Health Summit 2024
Dylan Scott, Karen Knudsen, Harlan Levine, Mohit Manrao, Kimryn Rathmell, AmirAli Talasaz
A comprehensive 24-million-person study spanning two decades reveals that 17 of 34 major cancer types are rising significantly among Millennials and Gen X, prompting the American Cancer Society to lower screening thresholds despite critical barriers in adoption and access. To address this "tsunami" of young survivors facing unique fertility, financial, and care challenges, the field is transitioning toward liquid biopsy innovations and multidisciplinary "living" guideline frameworks to bridge the gap between community providers and academic centers. While precision medicine and expanded immunotherapy trials offer hope for improved survival, the crisis persists due to outdated insurance models, systemic disparities, and a significant lag between emerging scientific evidence and updated clinical protocols.
- Milken Institute54 min
Connecting the Dots for Women's Health: Innovation, Access, & Care | Future of Health Summit 2024
Ruth Reader, Sandra Brooks, Trish Costello, Jenica Patterson, Ana Maria Ramirez, Tammy Sun
As of last week, ARPA-H has obligated $113 million in federal funding to support women's health research through Spark and Launchpad awards targeting conditions like Alzheimer's, endometriosis, and maternal mortality. This investment coincides with a 300% surge in venture capital for the sector since 2018, driving innovations in male contraception and non-pharmacological treatments despite persistent racial disparities and access barriers. While bipartisan funding provides short-term stability, experts warn that evolving legal landscapes regarding abortion and the politicization of data privacy pose significant risks to future reproductive health outcomes.
- Milken Institute40 min
Bot or Not?: AI in Health Care | Future of Health Summit 2024
Richard Lui, Dipanwita Das, John Halamka, Vidya Raman-Tangella
Industry leaders including Sociero CEO Dipanita Das, Mayo Clinic President Dr. John Halamka, and Teladoc CMO Vidya Rahman convened to argue that while technical barriers to healthcare AI have dissolved, cultural resistance and data heterogeneity now impede transformative progress. The panel highlighted critical successes such as Mayo Clinic's ability to detect Stage Zero pancreatic cancer and Teladoc's use of generative AI for personalized patient engagement, underscoring the necessity of embedding real-world evidence and clinical validation into care pathways. Ultimately, the group urged a strategic shift from adopting technology for novelty to solving specific operational problems, calling for a global federated data network to achieve a preventative "precision health" vision for four billion people by 2030.
- Milken Institute1h 0m
Building Safer Communities: Health Approaches to Gun Violence Prevention | Future of Health Summit
Omer Awan, Stefanie Feldman, Angela Ferrell-Zabala, Alex M. Johnson, Zachary Meisel, Chethan Sathya
Public health experts and university administrators gathered to strategize a shift toward community-based violence intervention focused on economic opportunity and data-driven safety for youth. The session highlighted a bipartisan legislative push for federal funding while emphasizing the need to bridge trust gaps with marginalized communities through localized, peer-led development models. Key stakeholders set a September 4th deadline for public-private collaboration and outlined plans to launch long-term investment initiatives that integrate food security and systemic change to address social determinants of health.
- Milken Institute31 min
Opening Remarks | Future of Health Summit 2024
The Milken Institute Future of Health Summit 2024 convenes over 200 global leaders across philanthropic, scientific, and governmental sectors to address critical health challenges like aging populations, rising chronic disease rates, and systemic access barriers. Featuring the theme "Partnering for Better Health," the event focuses on collaborative solutions to bridge the gap between massive healthcare investments and poor national outcomes, including a strategic shift from treatment to prevention. Discussions will examine how AI, biomedical innovation, and inclusive clinical trials can accelerate medical development while ensuring equitable access to care for diverse demographics.
- Milken Institute32 min
A Conversation with CDC Director Mandy Cohen | Future of Health Summit 2024
CDC Director Wendy Cohen reaffirmed the agency's commitment to core public health missions while detailing infrastructure upgrades including national wastewater monitoring and expanded emergency room data visibility to track emerging threats like avian flu. She highlighted a significant 13% year-over-year decline in fatal overdoses driven by new care strategies, though she warned that proposed budget cuts to suicide prevention programs pose severe risks to those under 50. Addressing recent vaccine skepticism and global measles surges, Cohen emphasized the urgent need to integrate healthcare delivery with public health operations to overcome funding gaps and restore public trust.
- Milken Institute22 min
A Conversation with FDA Commissioner Robert Califf | Future of Health Summit 2023
Robert Califf, Conrad Kiechel, Esther Krofah
FDA Commissioner Robert Califf highlighted a critical gap in U.S. health outcomes, noting that despite high spending, life expectancy has fallen to 76.4 years while fragmented post-market evidence systems fail to answer key treatment questions. To address this, Califf proposed a unified ecosystem involving the CMS, NIH, and FDA to leverage real-world data and AI for generating rigorous post-approval evidence while incentivizing clinicians to participate in large-scale research. Additionally, the agency plans to combat persistent public distrust and medical misinformation through plain-language communication and a broad coalition of academic, industry, and community partners.